Xeris Biopharma (XERS) 2025 Outlook: Earnings & Pipeline
A thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
Using financial plans to reach life objectives can streamline your path to success. Discover how to create a plan that works for you.
22,378 articlesA thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
Marvell Technology defied earlier sell-offs tied to fears of losing Amazon and Microsoft to rivals, reporting strong ...
Two EV giants, two different playbooks. This guide breaks down the Rivian vs Tesla story and helps you decide which c...
For years, headlines have proclaimed Bitcoin dead. Yet the asset keeps proving skeptics wrong. This article breaks do...
SoFi Technologies edges higher on Monday, breaking a prolonged skid as a key short-seller report lingers in the backg...
In a choppy market shaped by inflation and global tensions, three stocks stand out for potential to beat market retur...
DeFi endured its worst April in over a year, with hundreds of millions lost to hacks. The sector now faces a shift to...
MercadoLibre reports a robust Q1 2026 with revenue rising sharply, even as margins compress. Analysts increasingly vi...
As a looming recession tests crypto narratives, Bitcoin’s fixed supply and growing institutional interest face off ag...
Mid-career jobseekers are trimming resumes and curating online profiles as hiring cools and AI filters tighten. The t...
A 65-year-old retiree with $2.4 million uncovers a looming $58,000-a-year caregiver bill for an aging parent, prompti...
A new analysis warns that social security checks could fall about 24% by 2032 if the trust fund dries up, though bene...